What is the International Order Book?
London Stock Exchange International Order Book (IOB) enables investors to unlock the potential of some of the world’s fastest growing markets through a single central electronic order book. It offers easy, cost-efficient and direct access to securities via global depositary receipts (GDRs) from over 30 countries, including markets in Central and Eastern Europe, Asia and the Middle East. The market has grown rapidly since its inception in 2001, with Gazprom, Sberbank and Lukoil among the most heavily traded securities on London Stock Exchange. Shanghai-London Stock Connect GDRs are also traded on the International Order Book, on the Shanghai Segment.
Explore
Still have questions on IOB securities?
Find out about companies we have welcomed to our markets
London Stock Exchange welcomes Light Science Technologies Holdings plc
Today, London Stock Exchange welcomes Light Science Technologies Holdings plc (“LSTH”) to trading on AIM under the ticker LST. In October 2021, LSTH successfully raised gross proceeds of £5 million (the “Placing”) and the Company’s market capitalisation on admission was approximately £17.5 million.
The net proceeds of the Placing, which are receivable by the
London Stock Exchange welcomes Tortilla Mexican Grill plc to AIM
Tortilla Mexican Grill plc (MEX), the largest and most successful fast-casual Mexican restaurant group in the UK, began trading on Friday 8 October on London Stock Exchange’s AIM. The IPO raised £5.0m of gross proceeds, and upon Admission the Company’s market capitalisation was £70.0m.
Tortilla offers a high-quality, affordable and freshly prepared Californi
London Stock Exchange welcomes Oxford Nanopore Technologies plc to the Main Market
London Stock Exchange welcomes Oxford Nanopore Technologies plc to the Main Market of the London Stock Exchange. Founded in 2005 by Gordon Sanghera, Spike Willcocks and Professor Hagan Bayley, Oxford Nanopore has developed a new generation of nanopore-based sensing technology.
Oxford Nanopore’s long term goal is to bring the widest benefits to society throug
London Stock Exchange welcomes BioPharma Credit plc to the Premium Segment of the Main Market
BioPharma Credit, the specialist life sciences debt investor, today announces that its London listing has moved from the Specialist Fund Segment to the Premium Segment of the Main Market of London Stock Exchange. The Company’s objective in joining the Main Market is to raise the Company’s global profile, extend its potential shareholder base, and e